Abnormal eGFR Blood Test: What to Do Next, Which Kidney Specialist to See, and What Questions to Ask — A Patient-Centered Narrative Review
Updated: Sep 24
By Ori Scott, M.Sc. NutritionRegistered Dietitian (Israel)Founder, Healthy Habits Coaching
Abstract
An abnormal estimated glomerular filtration rate (eGFR) is a common laboratory finding that can generate considerable concern, particularly when a patient receives the result before having an opportunity to discuss it with a healthcare professional. An isolated abnormal eGFR, however, does not by itself establish chronic kidney disease (CKD), determine its cause, or indicate that kidney failure is imminent. Contemporary kidney-disease evaluation requires interpretation of eGFR together with urine albumin excretion, previous laboratory values, duration of the abnormality, medications, comorbid conditions, and the clinical circumstances surrounding testing.
This narrative review provides a practical pathway for adults who unexpectedly receive an abnormal eGFR result. The approach is based principally on the Kidney Disease: Improving Global Outcomes (KDIGO) framework, Kidney Disease Outcomes Quality Initiative (KDOQI) nutrition guidance, European and United Kingdom kidney-care principles, and patient guidance from major kidney organizations. Particular attention is given to confirming chronicity, obtaining urine albumin-to-creatinine ratio (uACR), distinguishing the roles of primary care, nephrology and urology, reviewing medications and supplements, and determining when medical nutrition therapy with a kidney-experienced dietitian may be appropriate.
The central message is that an abnormal eGFR should initiate a structured evaluation rather than immediate self-diagnosis or indiscriminate dietary restriction. The objective is to establish whether kidney dysfunction is persistent, determine its probable cause and severity, identify reversible or treatable contributors, estimate the risk of progression, and develop an individualized medical and nutritional management plan.
Keywords: abnormal eGFR; low eGFR; kidney function test; chronic kidney disease; CKD; creatinine; urine albumin-to-creatinine ratio; uACR; nephrologist; urologist; renal dietitian; kidney disease nutrition; KDIGO; KDOQI.
1. Introduction
An abnormal eGFR blood test is a common finding because estimated glomerular filtration rate is routinely reported as an indicator of kidney filtration. It is usually calculated from serum creatinine together with demographic variables using a validated estimating equation. Because eGFR appears automatically on many routine metabolic panels, patients may encounter an abnormal result during testing performed for hypertension, diabetes, cardiovascular risk assessment, an annual examination, medication monitoring, or an unrelated medical problem.
The natural reaction is often to search for the eGFR value online and compare it with a CKD staging table. Although staging tables are useful, this approach can lead to an important misunderstanding: an eGFR category is not, by itself, a complete kidney diagnosis.
CKD is defined by abnormalities of kidney structure or function that persist for at least three months and have implications for health. Evaluation therefore involves more than identifying a single laboratory value. Both glomerular filtration and markers of kidney damage—particularly albuminuria—are central to contemporary CKD classification and prognosis.
An unexpectedly abnormal eGFR should consequently be treated as the beginning of a clinical question:
Is this a persistent kidney abnormality, why is it occurring, and what should be done about it?
2. Understanding What eGFR Measures
Glomerular filtration rate represents the kidney's capacity to filter plasma. Direct measurement of GFR is possible but cumbersome, so routine clinical practice generally relies on an estimated GFR.
Serum creatinine is influenced not only by filtration but also by creatinine generation and other physiological factors. Muscle mass, age, nutritional status, certain medications, acute illness and unusual body composition can influence the relationship between serum creatinine and actual filtration.
For this reason, eGFR should be interpreted as an estimate, not as a direct measurement of kidney performance with perfect precision.
Current GFR categories are:
GFR category | eGFR (mL/min/1.73 m²) | Description |
G1 | ≥90 | Normal or high |
G2 | 60–89 | Mildly decreased |
G3a | 45–59 | Mildly to moderately decreased |
G3b | 30–44 | Moderately to severely decreased |
G4 | 15–29 | Severely decreased |
G5 | <15 | Kidney failure |
G1 or G2 does not establish CKD in the absence of another marker of kidney damage. Conversely, persistent albuminuria can identify kidney disease even when eGFR remains relatively preserved.
The clinical significance of an eGFR of 55, for example, therefore cannot be determined solely from the number 55.
3. Why One Abnormal eGFR Should Not Automatically Be Labeled CKD
The first clinical task after an unexpected abnormal result is to determine whether the abnormality represents a chronic condition or a temporary change.
Kidney filtration can change during acute illness, dehydration, vomiting or diarrhea, hemodynamic disturbances, urinary obstruction, medication exposure, infection and other acute circumstances. Laboratory and biological variation also occurs.
CKD, by definition, requires chronicity. Evidence can come from previous laboratory measurements, previous urine abnormalities, imaging findings, pathology, medical history, or persistence of abnormalities over time.
A patient seeing a low eGFR for the first time should therefore ask:
“Is there evidence that this has been present for at least three months, or could this be an acute or temporary change?”
Previous laboratory records can be exceptionally valuable. An eGFR of 52 that has remained near the same level for several years represents a different clinical situation from an eGFR that fell rapidly from 95 to 52.
4. The Second Kidney Number: Urine Albumin-to-Creatinine Ratio
A common problem in public understanding of kidney disease is excessive attention to eGFR and insufficient attention to albuminuria.
The urine albumin-to-creatinine ratio (uACR or ACR) estimates the amount of albumin being lost in urine. Persistent albuminuria is an important marker of kidney damage and independently contributes to the prediction of CKD progression and cardiovascular risk.
Albuminuria is generally categorized as:
Albuminuria category | uACR | Interpretation |
A1 | <30 mg/g | Normal to mildly increased |
A2 | 30–300 mg/g | Moderately increased |
A3 | >300 mg/g | Severely increased |
Results may also be reported in mg/mmol outside the United States.
Albuminuria can be temporarily elevated under some circumstances, and abnormal results may therefore require confirmation. The combination of GFR category and albuminuria category provides substantially more clinical information than either measurement alone.
A patient with an abnormal eGFR who has never had uACR measured should therefore ask whether urine albumin testing is appropriate.
5. What Should Happen After an Unexpected Abnormal eGFR?
For a clinically stable person who discovers an abnormal result on routine testing, primary care is usually an appropriate starting point.
The clinician can review the laboratory result in context, compare it with previous measurements, assess blood pressure and relevant medical conditions, review medications, determine whether repeat testing is necessary, request urine studies, and decide whether additional investigation or specialist referral is indicated.
A reasonable initial evaluation may include, depending on the individual:
repeat serum creatinine and eGFR;
uACR;
urinalysis;
blood pressure;
medication and supplement review;
potassium and other electrolytes;
bicarbonate;
glucose or HbA1c when relevant;
complete blood count or mineral-metabolism testing when clinically indicated; and
kidney or urinary-tract imaging when the history or laboratory findings suggest a structural problem.
Not every patient requires every test. Evaluation should be directed by the clinical context and suspected cause.
6. Nephrologist or Urologist: Which Kidney Specialist Is Appropriate?
The terms nephrologist and urologist are sometimes used interchangeably by patients, but the specialties have substantially different roles.
6.1 Nephrology
A nephrologist is a physician specializing in medical diseases of the kidneys.
Nephrology becomes particularly relevant when there is unexplained or progressive reduction in kidney function, substantial albuminuria or proteinuria, suspected glomerular disease, significant electrolyte or acid-base abnormalities, resistant hypertension associated with kidney disease, hereditary kidney disease, advanced CKD, or a sufficiently high predicted risk of progression.
Referral should not depend solely on an arbitrary eGFR threshold. Contemporary CKD care increasingly incorporates the rate of kidney-function decline, albuminuria, etiology, complications, and predicted kidney-failure risk.
6.2 Urology
A urologist specializes primarily in structural and surgical disorders of the urinary tract and male reproductive system.
Urological assessment may be particularly appropriate when the problem involves:
urinary obstruction;
kidney or ureteral stones;
hydronephrosis;
prostate-related urinary obstruction;
bladder disease;
structural urinary-tract abnormalities;
selected causes of hematuria; or
conditions requiring a urinary-tract procedure or surgery.
A patient may occasionally require both specialties. A person with an obstructing stone and impaired kidney function, for example, may require urological treatment of the obstruction together with nephrological assessment of kidney function.
7. When Should Nephrology Referral Be Considered?
Referral decisions are individualized. Features that should prompt consideration of specialist kidney assessment include substantial albuminuria, albuminuria accompanied by hematuria, rapidly declining kidney function, advanced reduction in eGFR, difficult-to-control hypertension, suspected systemic or glomerular disease, hereditary kidney disease, recurrent or severe electrolyte disturbances, uncertain etiology, or elevated predicted risk of kidney failure.
Risk-prediction tools are increasingly important in modern CKD care. In appropriate patients, validated kidney-failure risk equations can supplement traditional staging and help guide monitoring and referral decisions.
The practical question for a patient is therefore not simply:
“Is my eGFR low enough to see a nephrologist?”
A better question is:
“Considering my eGFR, urine albumin, rate of change, probable cause, complications and predicted progression risk, would nephrology referral improve my care?”
8. Medication and Supplement Review Is Part of the Kidney Evaluation
Medication reconciliation is an essential component of kidney assessment.
The patient should provide the clinician with a complete list of:
prescription medications;
over-the-counter medications;
pain relievers;
vitamins and minerals;
herbal preparations;
bodybuilding or sports supplements;
protein powders;
electrolyte powders or drinks;
potassium supplements; and
salt substitutes.
Nonsteroidal anti-inflammatory drugs (NSAIDs), including commonly used agents such as ibuprofen and naproxen, deserve particular attention because they can impair renal perfusion and increase acute kidney injury risk in susceptible individuals.
This does not mean that patients should independently discontinue prescribed medication after seeing an abnormal eGFR.
Some medications that alter kidney hemodynamics—including renin-angiotensin system inhibitors and sodium-glucose cotransporter-2 inhibitors—can provide substantial kidney protection in appropriately selected patients despite predictable changes in eGFR after treatment initiation.
Medication decisions therefore require clinical interpretation rather than a simple list of “kidney-safe” and “kidney-toxic” drugs.
9. The Role of the Registered Dietitian
An abnormal eGFR frequently leads patients to search for a “kidney diet.” This can result in unnecessary elimination of fruits, vegetables, legumes, dairy products, whole grains or protein-containing foods before CKD has even been confirmed.
There is no single renal diet appropriate for every person with an abnormal eGFR.
Medical nutrition therapy should consider:
CKD stage;
albuminuria;
serum potassium;
phosphorus and mineral metabolism when relevant;
bicarbonate and acid-base status;
blood pressure;
diabetes;
cardiovascular disease;
body composition;
appetite and nutritional status;
medications;
fluid status; and
dialysis status.
A registered dietitian with kidney-disease experience can translate these variables into an individualized eating pattern while reducing the risk of both excessive intake and unnecessary restriction.
Protein
Protein requirements should be individualized. In adults with nondialysis CKD, excessive protein intake may be undesirable, while excessive restriction can increase the risk of inadequate nutrition and protein-energy wasting.
Dialysis substantially changes protein requirements; recommendations for nondialysis CKD should therefore not simply be transferred to dialysis patients.
Sodium
Excessive sodium intake is relevant because of its relationships with blood pressure, extracellular volume and albuminuria. Dietary assessment should examine processed foods, restaurant meals, cured meats, sauces, packaged foods, instant products and other major sodium sources rather than focusing only on salt added at the table.
Potassium
CKD does not automatically require a low-potassium diet.
Serum potassium reflects kidney function, medications, acid-base status, insulin status, gastrointestinal function and other physiological factors in addition to dietary intake.
Broad elimination of potassium-rich plant foods without documented clinical need may unnecessarily reduce dietary quality. Potassium management should instead be based on laboratory findings and individual risk.
Potassium-containing supplements and potassium chloride salt substitutes deserve particular attention when hyperkalemia is present or likely.
Phosphorus
Phosphorus management should similarly consider laboratory findings and food source. Highly absorbable inorganic phosphate additives in processed foods are metabolically different from phosphorus naturally present in many plant foods, where a proportion is bound as phytate.
A renal dietitian can therefore help distinguish clinically meaningful dietary exposures from restrictions that provide little benefit.
10. What Patients Should Avoid Doing on Their Own
Until the clinical situation is understood, patients should generally avoid responding to an abnormal eGFR with aggressive self-treatment.
Particular caution is warranted with:
“kidney detox” products;
herbal kidney cleanses;
unverified supplements;
extreme protein restriction;
high-protein diets or large supplemental protein loads;
potassium supplements;
potassium-based salt substitutes;
indiscriminate low-potassium diets;
indiscriminate low-phosphorus diets; and
extreme fluid intake intended to “flush” the kidneys.
The appropriate objective is not maximum dietary restriction. It is an appropriate dietary and medical prescription for the individual's physiology and disease state.
11. When an Abnormal Kidney Result May Require Urgent Assessment
Routine outpatient evaluation is appropriate for many stable patients with mildly abnormal kidney laboratory results. Certain circumstances, however, require prompt medical assessment.
Urgency increases when kidney dysfunction occurs with acute illness, rapidly worsening laboratory results, very low or absent urine output, significant dehydration, severe swelling or breathing difficulty, severe electrolyte disturbances such as clinically significant hyperkalemia, severe acid-base disturbance, confusion, or other evidence of acute clinical deterioration.
The distinction between stable CKD and acute kidney injury is clinically important. A rapidly changing creatinine or eGFR should not be managed as though it were simply a stable chronic laboratory abnormality.
12. A Practical Model of Multidisciplinary Kidney Care
Kidney care is frequently multidisciplinary.
Primary-care physician or internist: initial evaluation, longitudinal monitoring, cardiovascular and metabolic risk management, medication review and coordination of referrals.
Nephrologist: diagnosis and management of medical kidney disease, CKD progression, albuminuria, glomerular disease, electrolyte and acid-base disorders, advanced CKD and kidney-failure planning.
Urologist: structural, obstructive and procedural disorders of the urinary tract.
Registered dietitian with kidney expertise: individualized medical nutrition therapy addressing protein, sodium, potassium, phosphorus, dietary quality, nutritional adequacy and relevant comorbidities.
Pharmacist: medication reconciliation, renal dosing, interaction review and medication-safety support.
The relative importance of each professional depends on the cause and severity of the kidney abnormality.
13. Conclusion
An unexpected abnormal eGFR should prompt systematic evaluation rather than immediate self-diagnosis.
The first objective is to establish whether the abnormality is persistent and whether it represents chronic kidney disease, an acute change, or another clinical circumstance affecting the estimate. Previous kidney-function results, repeat testing when appropriate, urine albumin measurement and clinical history are central to this process.
If CKD is confirmed, evaluation should move beyond the eGFR number to include albuminuria, probable cause, rate of progression, cardiovascular risk, medications, biochemical abnormalities and nutritional status.
Nephrology is principally concerned with medical kidney disease and impaired kidney function, whereas urology principally addresses structural and procedural disorders of the urinary tract. A kidney-experienced registered dietitian can provide individualized nutrition therapy when dietary intervention is appropriate.
Most importantly, an abnormal kidney test should not automatically trigger a highly restrictive “renal diet.” Contemporary kidney nutrition emphasizes individualized medical nutrition therapy based on kidney function, laboratory abnormalities, medications, nutritional status and the patient's broader clinical circumstances.
The appropriate sequence is therefore:
Confirm → classify → determine cause → assess risk → review medications → individualize nutrition → monitor.
PRINTABLE PATIENT WORKSHEET
My eGFR Is Abnormal: What Should I Do Next?
Bring this worksheet, your laboratory results, medication list and supplement list to your medical appointment.
PAGE 1 — MY KIDNEY NUMBERS
Name: ______________________________________
Date: _______________________________________
Current laboratory results
Creatinine: __________________ mg/dL
eGFR: __________________ mL/min/1.73 m²
Urine albumin-to-creatinine ratio (uACR): __________________
Potassium: __________________
Bicarbonate/CO₂: __________________
Blood pressure: __________ / __________ mmHg
HbA1c, if applicable: __________________
My previous kidney results
Date | Creatinine | eGFR | uACR |
__________ | __________ | __________ | __________ |
__________ | __________ | __________ | __________ |
__________ | __________ | __________ | __________ |
__________ | __________ | __________ | __________ |
Questions for my doctor
☐ Is this eGFR definitely abnormal for me?
☐ Could this result be temporary?
☐ Could dehydration, acute illness or medication have influenced it?
☐ How does it compare with my previous results?
☐ Should creatinine/eGFR be repeated?
Repeat test date: __________________
☐ Have I had a quantitative urine ACR?
☐ Does the abnormality meet criteria for chronic kidney disease?
☐ If CKD is present, what are my GFR and albuminuria categories?
G category: __________
A category: __________
☐ What do you think is causing the abnormal kidney findings?
☐ How quickly, if at all, is my kidney function changing?
PAGE 2 — SPECIALISTS, MEDICATIONS AND TESTING
Which professional do I need?
Ask about a NEPHROLOGIST if I have:
☐ Unexplained reduced kidney function
☐ Progressive eGFR decline
☐ Significant albumin/protein in urine
☐ Suspected medical or glomerular kidney disease
☐ Significant electrolyte or acid-base abnormalities
☐ Difficult-to-control hypertension
☐ Hereditary kidney disease
☐ Advanced CKD
☐ Elevated predicted kidney-failure risk
Nephrology referral recommended?
☐ Yes ☐ No ☐ Monitor first
Reason: _________________________________________________
Ask about a UROLOGIST if I have:
☐ Kidney/ureteral stones
☐ Urinary obstruction
☐ Hydronephrosis
☐ Prostate-related obstruction
☐ Bladder/urinary-tract abnormality
☐ Structural kidney/urinary-tract problem
☐ Hematuria requiring urological evaluation
Urology referral recommended?
☐ Yes ☐ No
Reason: _________________________________________________
Tests to discuss
☐ Repeat creatinine/eGFR
☐ uACR
☐ Urinalysis
☐ Potassium
☐ Bicarbonate/CO₂
☐ Other electrolytes
☐ Blood pressure
☐ Glucose/HbA1c
☐ CBC if indicated
☐ Calcium/phosphorus/PTH if indicated
☐ Kidney/urinary-tract ultrasound if indicated
☐ Cystatin C if additional GFR assessment would be useful
☐ Other: _________________________________________________
Medication and supplement review
Bring everything you take, including nonprescription products.
☐ Prescription medications
☐ Ibuprofen/naproxen/other NSAIDs
☐ Other OTC medications
☐ Vitamins
☐ Minerals
☐ Herbal products/teas
☐ Protein powders
☐ Sports/bodybuilding supplements
☐ Electrolyte powders/drinks
☐ Potassium supplements
☐ Salt substitutes
☐ “Detox” or “kidney cleanse” products
Questions
☐ Are any of my medications affected by my kidney function?
☐ Does any medication require dose adjustment?
☐ Should I avoid or limit NSAIDs?
☐ Are my supplements appropriate?
☐ Are any medications I take actually kidney-protective?
Do not independently stop a prescribed medication because of an abnormal eGFR unless instructed by the clinician responsible for your care.
PAGE 3 — NUTRITION AND MY FOLLOW-UP PLAN
Questions for my doctor or kidney-experienced dietitian
☐ Do I actually need a kidney-specific diet?
☐ What protein intake is appropriate for me?
Protein target: ______________________________
☐ What sodium intake is appropriate?
Sodium target: ______________________________
☐ Is my potassium abnormal?
Potassium: _________________________________
☐ Do I actually need dietary potassium restriction?
☐ Should I avoid potassium chloride salt substitutes?
☐ Is phosphorus restriction medically indicated?
☐ Should I specifically reduce foods containing phosphate additives?
☐ Is my current fluid intake appropriate?
☐ Are protein powders appropriate for me?
☐ Are electrolyte drinks appropriate for me?
☐ Am I at risk of inadequate nutrition or muscle loss?
☐ How should kidney nutrition be coordinated with diabetes, blood pressure or cardiovascular care?
My monitoring plan
Next creatinine/eGFR: _______________________
Next uACR: _________________________________
Next medical appointment: ___________________
Nephrology appointment: _____________________
Urology appointment: ________________________
Dietitian appointment: ______________________
My three most important questions
1. ______________________________________________________
2. ______________________________________________________
3. ______________________________________________________
My treatment priorities
1. ______________________________________________________
2. ______________________________________________________
3. ______________________________________________________
Before I leave the appointment, I understand:
☐ Whether CKD has actually been confirmed
☐ My eGFR trend
☐ My uACR result
☐ The suspected cause
☐ Whether additional testing is required
☐ Whether I need nephrology
☐ Whether I need urology
☐ Whether I need individualized nutrition counseling
☐ Which medications or supplements require review
☐ When my kidney tests should be repeated
☐ Which symptoms or laboratory abnormalities require urgent medical attention
Key Clinical References
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024.
Ikizler TA, Burrowes JD, Byham-Gray LD, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. American Journal of Kidney Diseases. 2020;76(3 Suppl 1)–S107.
National Kidney Foundation. Estimated Glomerular Filtration Rate (eGFR): kidney function, CKD stages and interpretation.
National Kidney Foundation. Urine Albumin-Creatinine Ratio (uACR): testing and interpretation.
National Institute for Health and Care Excellence (NICE). Chronic Kidney Disease: Assessment and Management (NG203). London: NICE.
Kidney Disease: Improving Global Outcomes (KDIGO). CKD classification, chronicity assessment, risk evaluation, medication stewardship and patient-centered management principles.
Educational and Medical Disclaimer
This narrative review and patient worksheet are provided for educational purposes and do not constitute individualized medical advice, diagnosis, prescribing guidance or treatment.
An abnormal eGFR requires interpretation in the context of previous kidney-function measurements, urine findings, medications, comorbid conditions, age, nutritional status and the circumstances surrounding testing. No medication should be initiated, discontinued or dose-adjusted solely on the basis of this article.
Dietary requirements vary substantially according to kidney function, albuminuria, serum potassium, phosphorus, bicarbonate, blood pressure, diabetes, cardiovascular disease, nutritional status, medications and dialysis status. Patients with abnormal kidney findings should obtain individualized assessment from appropriately qualified healthcare professionals.
Acute clinical deterioration, markedly reduced urine output, severe dehydration, severe electrolyte abnormalities, significant breathing difficulty or other potentially serious symptoms require prompt medical evaluation.
Author
Ori Scott, M.Sc. NutritionRegistered Dietitian (Israel)Founder, Healthy Habits Coaching
Comments